DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 74 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

Zydus Lifesciences Limited — Investor Presentation

NSE 23 Aug·23 Aug 2026, 7:09 am

Zydus Lifesciences

Zydus Lifesciences has submitted its investor presentation to the stock exchanges. This document typically outlines the company's strategic roadmap, financial performance, and future growth plans for the upcoming period.

For investors, this update is a key opportunity to understand management's outlook on market conditions and product pipelines. It provides clarity on how the company intends to navigate the competitive landscape and achieve its targets.

Investors should focus on the guidance provided regarding revenue growth, margin expansion, and the progress of key product launches. Monitoring the management's commentary during any subsequent earnings calls will also be important to gauge execution.